share_log

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response C

Benzinga ·  Apr 9, 2021 23:24
Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response Coordinator Jeff Zients recently said the US in on track of meeting the goal of 100 million shots in 100 days.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment